Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors

CHAPTER 8 Fragment-Based Discovery of Antibacterials

ChemInform Abstract: Regioselective Conversion of Arenes to N‐Aryl‐1,2,3‐triazoles Using C—H Borylation.

Understanding "On-Water" Catalysis of Organic Reactions. Effects of H⁺ and Li⁺ Ions in the Aqueous Phase and Nonreacting Competitor H-Bond Acceptors in the Organic Phase: On H₂O versus on D₂O for Huisgen Cycloadditions

Fragment-based discovery of antibacterials

Natural product-inspired fragment-based drug discovery: Development of M. tuberculosis CYP121 inhibitors

Fragment-based drug discovery of potent and selective CYP121 inhibitors for tuberculosis

Small‐Molecule Inhibitors That Target Protein–Protein Interactions in the RAD51 Family of Recombinases

Regioselective Conversion of Arenes to N‐aryl‐1,2,3‐triazoles Using CH Borylation

Overcoming the limitations of fragment merging: Rescuing a strained merged fragment series targeting mycobacterium tuberculosis CYP121